Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF230 divergent transcript (ZNF230-DT) is a non-coding RNA gene found on human chromosome 19 (chr19:43996896-44003298, hg38)[5]. It is classified as a long non-coding RNA (lncRNA), meaning it does not code for a protein product. The exact biological function of ZNF230-DT is currently not established or characterized in the scientific literature, and there are no documented roles in diseases, nor are there associated drugs, mechanisms of action, biomarker status, or safety concerns[3][5]. It is distinctly different from the protein-coding ZNF230 gene (zinc finger protein 230), with no clear evidence indicating ZNF230-DT is a therapeutic target or is implicated in any molecular family such as receptors, enzymes, ion channels, or transporters based on available data[3][5][7]. If additional or structured information is sought in the future, refer to comprehensive genome and transcript databases, but as of now ZNF230 divergent transcript should be understood only as a long non-coding RNA without established biological or therapeutic targeting relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF230 divergent transcript (ZNF230-DT).